The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
出版年份 2018 全文链接
标题
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume 244, Issue 5, Pages 538-549
出版商
Wiley
发表日期
2018-01-18
DOI
10.1002/path.5034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
- (2017) Casey M. Cosgrove et al. GYNECOLOGIC ONCOLOGY
- Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma
- (2017) Mariano Russo et al. HUMAN PATHOLOGY
- Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years
- (2017) Antonios Anagnostopoulos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium
- (2017) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
- (2017) Antonia R. Sepulveda et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing
- (2017) Jonathan A. Nowak et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The genetic landscape of endometrial clear cell carcinomas
- (2017) Deborah F DeLair et al. JOURNAL OF PATHOLOGY
- CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
- (2017) Katherine C Kurnit et al. MODERN PATHOLOGY
- Novel Implications in Molecular Diagnosis of Lynch Syndrome
- (2017) Raffaella Liccardo et al. Gastroenterology Research and Practice
- Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition
- (2017) Florine A. Eggink et al. OncoImmunology
- Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma
- (2016) Jaclyn C. Watkins et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
- (2016) Louis JM van der Putten et al. BRITISH JOURNAL OF CANCER
- Regression of Chemotherapy-Resistant Polymerase (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab
- (2016) A. D. Santin et al. CLINICAL CANCER RESEARCH
- Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
- (2016) M. K. McConechy et al. CLINICAL CANCER RESEARCH
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma
- (2016) T.P. Batista et al. EJSO
- Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
- (2016) Martin Köbel et al. GYNECOLOGIC ONCOLOGY
- Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
- (2016) Aline Talhouk et al. GYNECOLOGIC ONCOLOGY
- TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers
- (2016) Anne M. Schultheis et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
- (2016) Janice M. Mehnert et al. JOURNAL OF CLINICAL INVESTIGATION
- Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels
- (2016) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Erratum: Molecular genetic heterogeneity in undifferentiated endometrial carcinomas
- (2016) Juan M Rosa-Rosa et al. MODERN PATHOLOGY
- Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
- (2016) Inge C Van Gool et al. MODERN PATHOLOGY
- Neoepitopes and CD3-Positive and CD8-Positive Cells in Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers
- (2016) Inge C. van Gool et al. JAMA Oncology
- Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
- (2015) S Bendifallah et al. BRITISH JOURNAL OF CANCER
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
- (2015) I. C. van Gool et al. CLINICAL CANCER RESEARCH
- Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas
- (2015) M.K. McConechy et al. GYNECOLOGIC ONCOLOGY
- Histopathological features of endometrial carcinomas associated withPOLEmutations: implications for decisions about adjuvant therapy
- (2015) Salwa Bakhsh et al. HISTOPATHOLOGY
- Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria
- (2015) Tae Wook Kong et al. Journal of Gynecologic Oncology
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
- (2015) Brooke E. Howitt et al. JAMA Oncology
- L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
- (2014) T. Bosse et al. EUROPEAN JOURNAL OF CANCER
- Mismatch repair pathway
- (2014) Aga Syed Sameer et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication
- (2014) Eve Shinbrot et al. GENOME RESEARCH
- 1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial
- (2014) D.S. McMeekin et al. GYNECOLOGIC ONCOLOGY
- Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer
- (2014) Mariam M. AlHilli et al. GYNECOLOGIC ONCOLOGY
- DNA polymerase ε and its roles in genome stability
- (2014) Erin E. Henninger et al. IUBMB LIFE
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
- (2014) Yaser R Hussein et al. MODERN PATHOLOGY
- Practice Bulletin No. 147
- (2014) OBSTETRICS AND GYNECOLOGY
- Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
- (2014) Siân Jones et al. Nature Communications
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) N. Colombo et al. ANNALS OF ONCOLOGY
- Lack of Estrogen Receptor- Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
- (2013) Jone Trovik et al. EUROPEAN JOURNAL OF CANCER
- DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer
- (2013) David N. Church et al. HUMAN MOLECULAR GENETICS
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Reproducibility of histological cell type in high-grade endometrial carcinoma
- (2013) Guangming Han et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤70years
- (2012) Celine H.M. Leenen et al. GYNECOLOGIC ONCOLOGY
- Endometrial Carcinomas
- (2011) Carla Bartosch et al. ADVANCES IN ANATOMIC PATHOLOGY
- Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
- (2011) Scott M. Weissman et al. Journal of Genetic Counseling
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible
- (2010) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
- (2010) Abdulmohsen Alkushi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis
- (2010) Yukiharu Todo et al. LANCET
- Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma
- (2010) Geoffrey Hall et al. PATHOLOGY
- Are Uterine Risk Factors More Important Than Nodal Status in Predicting Survival in Endometrial Cancer?
- (2009) Janice S. Kwon et al. OBSTETRICS AND GYNECOLOGY
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging
- (2008) Andrea Mariani et al. GYNECOLOGIC ONCOLOGY
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
- (2008) C. Blake Gilks et al. HUMAN PATHOLOGY
- Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
- (2008) Marjolijn J L Ligtenberg et al. NATURE GENETICS
- Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
- (2007) Nobuyuki Susumu et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now